Skip to main content
. 2013 Apr 8;8(4):e60759. doi: 10.1371/journal.pone.0060759

Table 1. Clinical Characteristics of the 4 Study Groups.

GROUPS 1 2 3 4
Recurrent Events (n = 25) Single Remote MI (n = 25) Longstanding AlwaysStable CAD (n = 25) No CAD (n = 25)
Age (years) 65.6±8.4* 64.6±7.2 66.3±6.4 61.2±8.0
Sex (male) 88% (22) 84% (21) 88% (22) 72% (18)
BMI (kg/m2) 29.9±4.1 28.6±3.0 28.4±3.4 29.4±5.2
BMI >30 52% (13) 28% (7) 28% (7) 38% (9)
Waist circumference (cm) 103.7±10.7 98.4±10.4 99.2±11.5 96.3±12.7
Current smoker 28% (7) 12% (3) 16% (4) 12% (3)
Ex-smoker 60% (15) 72% (18) 56% (14) 60% (15)
Never smoker 12% (3) 16% (4) 28% (7) 28% (7)
Type 2 diabetes 32% (8) 16% (4) 28% (7) 0%
Hypertension 80% (20) 48% (12) 72% (18) 52% (13)
Dyslipidemia 100% (25) 96% (24) 96% (24) 36% (9)
1st cholesterol value (mmol/L) 3.81±0.94 3.94±0.47 3.96±0.72 4.79±0.94
History of renal failure 8% (2) 0% 4% (1) 4% (1)
Serum creatinine (µmol/L) 89.2±24.6 88.9±24.7 83.2±16.8 80.5±11.7
Urinary albumin/creatinine ratio 25.7±33.5 7.4±9.7 28.7±35.2 12.5±23.1
History of heart failure 32% (8) 0% 0% 0%
LV ejection fraction (%) 46±12 54±9 64±7 62±5
Duration CAD (years) 19.0±10.1 12.0±4.4 16.7±7.9
Stroke/TIA 4% (1) 0 4% (1) 0
Peripheral arterial disease 20% (5) 0 12% (3) 0
Ankle/brachial index 1.1±0.4 1.2±0.2 1.2±0.3 1.2±0.1
Medications
Lipid-lowering drugs 96% (24) 96% (24) 92% (23) 40% (10)
Angiotensin modulators 72% (18) 44% (11) 36% (9) 8% (2)
Beta-blockers 88% (22) 68% (17) 72% (18) 28% (7)
Aspirin/antiplatelet drugs 96% (24) 100% (25) 96% (24) 44% (11)
*

± refers to standard deviation values;

numbers of subjects in parentheses; MI = myocardial infarction; CAD = coronary artery disease; BMI = body mass index; LV = left ventricular; TIA = transient ischemic attack.